Kolkata, Jan 4 : City-based Medica Superspecialty Hospital, in association with Kings College, London and UK-based Britannia Pharmaceuticals, today launched a revolutionary treatment that will change the way Parkinson’s disease is being treated in eastern India.
‘Apomorphine Pen & Pump’ is the treatment that will radically change the life of a Parkinson’s patient, experts said on the occasion.
The increase in life expectancy has led to a new set of medical disorders which are called as “Aging related Degenerative Diseases”. Among these disorders Alzheimer's and Parkinson’s disease are important. Parkinson’s disease is characterized by slowness, stiffness and tremors, the treatment for which is either oral medical treatment or expensive surgical options like Deep brain stimulation (DBS), a neurosurgical procedure involving the implantation of a medical device sometimes referred to as a brain pacemaker.
'Apomorphine is a highly selective Dopamine receptor emulator, which promotes the release of Dopamine in the brain from the nerve cells,' explained Dr Sunandan Basu, Consultant Neurosurgeon, Medica Superspecialty Hospital.
Prof Kalyan Bhattacharya, Consultant Parkinson’s Disease and Movement Disorders Specialist, Medica Superspecialty Hospital said, 'DBS is not a choice for all ages and stages of Parkinson’s disease. Hence there are limitations and there is a need for therapeutic options in moderately advanced Parkinson’s disease.'
Dr. Laxmi Narayan Tripathy, Senior Vice-Chairman, Director and Senior Consultant, Neuro & Spine Surgeon, Medica Superspecialty Hospital said, 'Apomorphine is a wonderful option in treating Parkinson’s disease especially in advanced disease.'
Dr. Alok Roy, Chairman, Medica Group of Hospitals said they were privileged to have Kings College, London and Britannia Pharmaceuticals, with them for the launch of Apomorphine PEN & PUMP. 'We wish to transfer the benefits of this medicines to our patients in eastern part of India,' he said.
Dr. Vinod Metta, Consultant Interventional Neurologist, Kings College Hospital, London, & Medical advisor to Britannia Pharmaceuticals India, informed that Apomorphine pens work dramatically on patients within a couple of minutes and are very similar to usage to that of Insulin Pens. (UNI)